Benzinga

Benzinga

Benzinga

giovedì, settembre 03

Healthcare Realty Trust Inc

HRNYSE
Trade with Public
Trade with Public
$19.30
-0.06-0.31%
In chiusura: Sep 1, 5:00 PM EST
$19.30
-0.06-0.31%
Pre-mercato: 8:31 AM EST
PanoramicaNotiziePrevisioni utiliObiettivi di prezzoDati finanziariSentimentAzionariatoDividendiConfrontaOpzioniRapporto azionario

Healthcare Realty Trust Analyst Price Targets

Wall Street analyst price targets and consensus rating for Healthcare Realty Trust (HR).

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

3Buy
8Hold
Consensus RatingNeutral# Analysts11Avg. Consensus PT$20Upside to Avg. PT+2.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 1, 2026Wells FargoJohn KilichowskiPT CutEqual-Weight$21→$20
Aug 7, 2026RBC CapitalMichael CarrollPT RaiseSector Perform$21→$22
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Lowers Price Target to $20

Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Weight and lowers the price target from $21 to $20.
Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Healthcare Realty Trust, Raises Price Target to $22

RBC Capital analyst Michael Carroll maintains Healthcare Realty Trust (NYSE:HR) with a Sector Perform and raises the price target from $21 to $22.
Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Healthcare Realty Trust, Raises Price Target to $24

Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Overweight and raises the price target from $22 to $24.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $21

JP Morgan analyst Michael Mueller maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and raises the price target from $19 to $21.
Benzinga Newsdesk

PRO
UBS Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $21

UBS maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and raises the price target from $20 to $21.
Benzinga Newsdesk

PRO
Raymond James Reinstates Outperform on Healthcare Realty Trust, Announces $24 Price Target

Raymond James analyst David Rodgers reinstates Healthcare Realty Trust (NYSE:HR) with a Outperform and announces $24 price target.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved